Biomolecular Life Holdings Inc Statistics
Biomolecular Life Holdings Inc (BIOM) Stock Statistics & Valuation Metrics
Total Valuation
Biomolecular Life Holdings Inc has a market cap or net worth of $632.86K. The enterprise value is $421.91B.
- Market Cap
- $632.86K
- Enterprise Value
- $421.91B
Share Statistics
Biomolecular Life Holdings Inc has 1,054,774 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,054,774
- Owned by Insiders
- ―
- Owned by Institutions
- 0.02%
Financial Efficiency
Biomolecular Life Holdings Inc’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is 0.98%.
- Return on Equity (ROE)
- -0.46
- Return on Assets (ROA)
- 0.00
- Return on Invested Capital (ROIC)
- 0.98%
- Return on Capital Employed (ROCE)
- 0.01
- Revenue Per Employee
- 0
- Profits Per Employee
- 2.12M
- Employee Count
- 1
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Biomolecular Life Holdings Inc is -0.79. Biomolecular Life Holdings Inc’s PEG ratio is 0.00.
- PE Ratio
- -0.79
- PS Ratio
- 0.00
- PB Ratio
- 0.00
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Biomolecular Life Holdings Inc had revenue of 0 and earned 2.12M in profits. Earnings per share was 4.00.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -23.76K
- Pretax Income
- 2.12M
- Net Income
- 2.12M
- EBITDA
- 2.39M
- Earnings Per Share (EPS)
- 4.00
Cash Flow
In the last 12 months, operating cash flow was -32.27K and capital expenditures 0, giving a free cash flow of -32.27K billion.
- Operating Cash Flow
- -32.27K
- Free Cash Flow
- -32.27K
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Biomolecular Life Holdings Inc pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- -84.18%
Stock Price Statistics
- Beta
- 91.71
- 52-Week Price Change
- -4.61%
- 50-Day Moving Average
- 0.63
- 200-Day Moving Average
- 0.49
- Relative Strength Index (RSI)
- 43.77
- Average Volume (3m)
- 5,525
Financial Position
Biomolecular Life Holdings Inc as a current ratio of 0.00, with Debt / Equity ratio of -47.24%
- Current Ratio
- 0.00
- Quick Ratio
- 0.00
- Debt to Market Cap
- 2.00
- Net Debt to EBITDA
- 0.91
- Interest Coverage Ratio
- -0.48
Taxes
In the past 12 months, Biomolecular Life Holdings Inc has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Biomolecular Life Holdings Inc EV to EBITDA ratio is -0.78, with an EV/FCF ratio of 0.00.
- EV to Sales
- 0.00
- EV to EBITDA
- -0.78
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Biomolecular Life Holdings Inc has $0.00 in cash and marketable securities with $2.11M in debt, giving a net cash position of -$2.11M billion.
- Cash & Marketable Securities
- $0.00
- Total Debt
- $2.11M
- Net Cash
- -$2.11M
- Net Cash Per Share
- -$2.00
- Tangible Book Value Per Share
- $0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Biomolecular Life Holdings Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -17.52%
